Abstract
Regular access to health services is critical in optimizing the health of patients with Duchenne and Becker muscular dystrophy (MD), and access to new therapies often occurs through neurology visits. We aim to characterize healthcare use across specialties in patients with MD in the United States. Males <18y at time of first claim for hereditary progressive MD (index date) with continuous enrolment for ≥12 months post-index date were identified from the Truven Health Analytics MarketScan Database (2013-2018).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have